Internal Medicine, Nephrology · San Antonio, TX
NPI
1699161240
Since 2015
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1055 Ada St
San Antonio, TX, 78223
Phone (210) 358-5515
Groups this clinician bills Medicare through
Medicare paid, 2024
$153K
1,880 services
Medicare patients, 2024
572
Average age 75
Drug cost, 2024
$926K
2,439 prescriptions
Company payments, 2025
$1,322
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hamza Arif was code 99214 (office e&m - established), 467 times for 288 patients. In total Hamza Arif billed 1,880 services in 21 codes, and Medicare paid $153K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 467 | 288 | $62.64 | $29K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 406 | 284 | $12.19 | $4,948 |
| 99232 Hospital E&M - Subsequent | Facility | 238 | 101 | $57.91 | $14K |
| 90960 ESRD Related Services (not dialysis) | Office | 136 | 60 | $257.58 | $35K |
| 99233 Hospital E&M - Subsequent | Facility | 113 | 48 | $87.48 | $9,885 |
| 99223 Hospital E&M - Initial | Facility | 103 | 96 | $125.12 | $13K |
| 90966 ESRD Related Services (not dialysis) | Office | 81 | 26 | $211.59 | $17K |
| 99213 Office E&M - Established | Office | 68 | 64 | $54.17 | $3,683 |
| 99204 Office E&M - New | Office | 62 | 62 | $118.12 | $7,323 |
| 90935 Hemodialysis | Facility | 59 | 31 | $51.86 | $3,060 |
| 90961 ESRD Related Services (not dialysis) | Office | 37 | 30 | $211.79 | $7,836 |
| 99215 Office E&M - Established | Office | 18 | 12 | $80.62 | $1,451 |
By year: 2022 $221K for 2,189 services; 2023 $165K for 1,543 services; 2024 $153K for 1,880 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 63 | 63 | $3.45 | $217 |
Medicare prescription drug claims, 2024
In 2024, the drug Hamza Arif prescribed most often to Medicare patients was Jardiance (Empagliflozin), with 251 prescriptions and refills. In total Hamza Arif wrote 2,439 Medicare prescriptions that cost $926K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jardiance Empagliflozin | 251 | 500 | 81 | $285K |
| Farxiga Dapagliflozin Propanediol | 231 | 394 | 60 | $215K |
| Furosemide Generic | 184 | 359 | 61 | $740 |
| Losartan Potassium Generic | 184 | 501 | 73 | $1,340 |
| Amlodipine Besylate Generic | 180 | 461 | 71 | $953 |
| Kerendia Finerenone | 142 | 235 | 32 | $148K |
| Clinisol Parenteral Amino Acid 15% No.5 | 102 | 102 | Under 11 | $15K |
| Potassium Chloride Generic | 99 | 181 | 40 | $1,536 |
| Prosol Parenteral Amino Acid 20% No.1 | 77 | 77 | Under 11 | $15K |
| Chlorthalidone Generic | 73 | 180 | 28 | $910 |
| Spironolactone Generic | 69 | 187 | 25 | $448 |
| Lisinopril Generic | 64 | 139 | 20 | $347 |
| Carvedilol Generic | 61 | 151 | 25 | $248 |
| Calcium Acetate Generic | 61 | 83 | 21 | $2,836 |
| Nifedipine Er Nifedipine | 47 | 89 | 15 | $1,613 |
Brand drugs: 827 claims; generic drugs: 1,612 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hamza Arif $1,322 ($1,322 in general payments such as food, travel and fees) from 20 companies. The largest payer was Ardelyx, Inc. with $170.
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. ARDX | 7 | $170 |
| Mallinckrodt Hospital Products Inc. | 4 | $154 |
| Calliditas Therapeutics US Inc. | 8 | $138 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 5 | $113 |
| Akebia Therapeutics Inc AKBA | 4 | $112 |
| Travere Therapeutics, Inc. TVTX | 7 | $90.92 |
| ANI Pharmaceuticals, Inc. ANIP | 5 | $80.58 |
| Vifor Pharma, Inc. | 3 | $68.53 |
| Apellis Pharmaceuticals, Inc. APLS | 2 | $47.04 |
| Amgen Inc. AMGN | 3 | $44.55 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.